Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Burdock Root

Report On Contaminated Drinking Water At Camp Lejeune
Two chemicals - trichloroethylene (TCE) and tetrachloroethylene (PCE) - found to have contaminated drinking water at Marine Corps Base Camp Lejeune from the 1950s to 1985 have been linked to certain diseases and disorders, including various cancers. A new report from the National Research Council, Contaminated Water Supplies at Camp Lejeune - Assessing Potential Health Effects, reviews scientific evidence about the potential adverse health effects that could occur after exposure to TCE, PCE, and other contaminants; recommends the usefulness of conducting additional studies on former residents of the base; and identifies scientific considerations that could help the U.S. Department of the Navy, under which the Marine Corps operates, set priorities on future actions. The report will be released at a 90-minute public briefing.
generic viagra online
Prostate Cancer Screening Has Yet To Prove Its Worth
The recent release of two large randomized trials suggests that if there is a benefit of screening, it is, at best, small, says a new report in CA: A Cancer Journal for Clinicians. Authored by Otis W. Brawley, M.D. of the American Cancer Society and Donna Ankerst, Ph.D. and Ian M. Thompson, M.D. of the University of Texas Health Science Center at San Antonio, the review says because prostate cancer is virtually ubiquitous in men as they age, it is clear that a goal of "finding more cancers" is not acceptable. Instead, public health principles demand that screening must reduce the risk of death from prostate cancer, reduce the suffering from prostate cancer, or reduce health care costs when compared with a non-screening scenario. The authors suggest prostate cancer screening has yet to reach one of these standards to date.
News of the day
As They Debate Health Overhaul, Politicians Keep Eye On 2010
"Fifteen months before the midterm congressional election, health care is appearing in candidate stump speeches and interviews - particularly by Republican challengerṣ€¦ running in districts recently claimed by Democrats," USA Today reports. "That dynamic helps explain why a $1 trillion-plus health care bill stalled last week in Congress. ̣€¦ Obama has said he wants lawmakers to finish health care by the end of the year, in part because it could become mired in election-year politics. All 435 members of the House and 36 members of the Senate are up for election in 2010."
Medical Devices

Schering-Plough Announces Phase II And III Data For Corifollitropin Alfa

in ART procedures. Oral presentation at 25th European Society of Human Reproduction and Embryology (ESHRE) on June 29, 2009. Abstract no. O-005 2. Behr B,et al Corifollitropin alfa versus recombinant FSH treatment in controlled ovarian stimulation: equal efficacy in terms of oocyte and embryo quality. Oral presentation at 25th European Society of Human Reproduction and Embryology (ESHRE) on June 29, 2009. Abstract no O-003 3. Doody K et al, Puregon reference-"Success rates of a fixed rFSH/GnRH antagonist protocol are not affected by enodgenous LH levels. Oral presentation at 25th European Society of Human Reproduction and Embryology (ESHRE) on July 1, 2009. Abstract no. O-255 4. Ledger W et al, Two doses of corifollitropin alfa allow for similar exposure and ovarian response in patients weighing less than or equal to 60 kg and > 60 kg. Oral presentation at 25th European Society of Human Reproduction and Embryology (ESHRE) on July 1, 2009. Abstract no. O-282 5. Hillensjo T et al, Corifollitropin alfa versus recombinant FSH in a GnRH antagonist protocol for controlled ovarian stimulation in women weighing 60 kg or less. Oral presentation at 25th European Society of Human Reproduction and Embryology (ESHRE) on June 29, 2009. Abstract no. O-004 6. Fatemi HM et al, The first pilot study with corifollitropin alfa in a long GnRH agonist protocol indicates the development of a large cohort of follicles during the first week of ovarian stimulation. Oral presentation at 25th European Society of Human Reproduction and Embryology (ESHRE) on July 1, 2009. Abstract no. O-283 7. Frequently Asked Questions About Infertility. American Society for Reproductive Medicine Web site. http://www.asrm.org/Patients/faqs.html. Accessed May 14, 2009 8. http://www.icsi.ws/about_infertility. Accessed May 14, 2009 9. Frequently Asked Questions; Questions about Infertility. Centre for Fertility and Reproductive Medicine. http://www.csmc.edu/3830.html. Accessed May 14, 2009 Schering-Plough

Pages: 1 [2] 


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009